Showing results (11-20 of 43) with videos related to
Sort By:
Pageof 5
Genetics|September 8, 2019
Interpreting Coronary Artery Disease Risk Through Gene-Environment Interactions in Gene RegulationAnthony S Findley, Allison L Richards, Cristiano Petrini, et al.Cell Reports|November 24, 2021
Interspecies variation in hominid gut microbiota controls host gene regulationAmanda L Muehlbauer, Allison L Richards, Adnan Alazizi, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 20, 2023
Clinical Benefit From Immunotherapy in Patients With SCLC Is Associated With Tumor Capacity for Antigen PresentationCharles M Rudin, David Balli, W Victoria Lai, et al.Elife|May 14, 2021
Functional dynamic genetic effects on gene regulation are specific to particular cell types and environmental conditionsAnthony S Findley, Alan Monziani, Allison L Richards, et al.Genome Research|December 10, 2016
High-throughput allele-specific expression across 250 environmental conditionsGregory A Moyerbrailean, Allison L Richards, Daniel Kurtz, et al.Journal for Immunotherapy of Cancer|September 29, 2024
A multicenter, randomized, non-comparative, phase II study of nivolumab ± ipilimumab for patients with metastatic sarcoma (Alliance A091401): expansion cohorts and correlative analysesNathan D Seligson, James L Chen, Austin C Goodrich, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 26, 2025
Gene Copy Deletion of STK11, KEAP1, and SMARCA4: Clinicopathologic Features and Association With the Outcomes of Immunotherapy With or Without Chemotherapy in Nonsquamous NSCLCMalini M Gandhi, Arielle Elkrief, Catherine Gutierrez Moore, et al.Nature|May 29, 2020
Phase and context shape the function of composite oncogenic mutationsAlexander N Gorelick, Francisco J Sánchez-Rivera, Yanyan Cai, et al.Cell Reports|December 2, 2020
Concurrent Mutations in STK11 and KEAP1 Promote Ferroptosis Protection and SCD1 Dependence in Lung CancerCorrin A Wohlhieter, Allison L Richards, Fathema Uddin, et al.Journal for Immunotherapy of Cancer|November 1, 2023
Multi-institutional analysis of aneuploidy and outcomes to chemoradiation and durvalumab in stage III non-small cell lung cancerJoao V Alessi, Adam Price, Allison L Richards, et al.Pageof 5